neostigmine has been researched along with Sleep Apnea, Obstructive in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Sleep Apnea, Obstructive: A disorder characterized by recurrent apneas during sleep despite persistent respiratory efforts. It is due to upper airway obstruction. The respiratory pauses may induce HYPERCAPNIA or HYPOXIA. Cardiac arrhythmias and elevation of systemic and pulmonary arterial pressures may occur. Frequent partial arousals occur throughout sleep, resulting in relative SLEEP DEPRIVATION and daytime tiredness. Associated conditions include OBESITY; ACROMEGALY; MYXEDEMA; micrognathia; MYOTONIC DYSTROPHY; adenotonsilar dystrophy; and NEUROMUSCULAR DISEASES. (From Adams et al., Principles of Neurology, 6th ed, p395)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with obstructive sleep apnea (OSA) may be at higher risk of complications related to the use of NMBD." | 2.58 | Postoperative complications with neuromuscular blocking drugs and/or reversal agents in obstructive sleep apnea patients: a systematic review. ( Chung, F; Hafeez, KR; Nagappa, M; Singh, M; Tuteja, A; Wong, DT; Wong, J, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Korkmaz, MO | 1 |
| Sayhan, H | 1 |
| Guven, M | 1 |
| Hafeez, KR | 1 |
| Tuteja, A | 1 |
| Singh, M | 1 |
| Wong, DT | 1 |
| Nagappa, M | 1 |
| Chung, F | 1 |
| Wong, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Type II Diabetes Mellitus With Neuropathy on the Clinical Use of Rocuronium: A Pharmacodynamic Modelling Study[NCT03737942] | 60 participants (Anticipated) | Observational | 2018-11-15 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for neostigmine and Sleep Apnea, Obstructive
| Article | Year |
|---|---|
Postoperative complications with neuromuscular blocking drugs and/or reversal agents in obstructive sleep apnea patients: a systematic review.
Topics: Humans; Neostigmine; Neuromuscular Blocking Agents; Parasympathomimetics; Postoperative Complication | 2018 |
1 trial available for neostigmine and Sleep Apnea, Obstructive
| Article | Year |
|---|---|
Does sugammadex decrease the severity of agitation and complications in pediatric patients undergoing adenotonsillectomy?
Topics: Adenoidectomy; Adolescent; Anesthesia, General; Atropine; Child; Child, Preschool; Cough; Double-Bli | 2019 |